- Home
- ARMP vs ORMP Comparison
ARMP vs ORMP Comparison
Compare ARMP & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARMP | ORMP |
|---|---|---|
| Founded | N/A | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 125.7M | 117.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ARMP | ORMP |
|---|---|---|
| Price | $6.42 | $3.45 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | 54.2K | ★ 324.8K |
| Earning Date | 03-19-2026 | 11-13-2025 |
| Dividend Yield | N/A | ★ 7.18% |
| EPS Growth | N/A | ★ 838.25 |
| EPS | N/A | ★ 1.03 |
| Revenue | ★ $5,054,000.00 | $2,000,000.00 |
| Revenue This Year | $4.48 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $3.39 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.90 | $1.82 |
| 52 Week High | $16.34 | $3.71 |
Technical Indicators
Market Signals| Indicator | ARMP | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 51.52 | 57.20 |
| Support Level | $5.75 | $3.33 |
| Resistance Level | $6.37 | $3.60 |
| Average True Range (ATR) | 0.74 | 0.22 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 33.19 | 43.48 |
Price Performance
Historical ComparisonAbout ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.